SCHEMBL6489624

SCHEMBL6489624

CC(=O)O[C@@H](C)CCCCn1c(=O)cc(N)n(N(C)C=O)c1=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6284276 0.82 HPGD (0.42) ALDH1A1
SCHEMBL6284279 0.82 HPGD (0.42) ALDH1A1
SCHEMBL6348586 0.69 KDM4E (0.31) ALDH1A1
SCHEMBL764363 0.69 HTR1A (0.34) —
SCHEMBL6346928 0.68 ALDH1A1 (0.40) ALDH1A1
SCHEMBL6356082 0.67 LMNA (0.34) ALDH1A1
SCHEMBL6356080 0.67 LMNA (0.34) ALDH1A1
SCHEMBL15423260 0.66 HTR1A (0.32) —
SCHEMBL764388 0.65 HTR1A (0.32) —
SCHEMBL764366 0.65 HTR1A (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6878715-B1 Therapeutic compounds for inhibiting interleukin-12 signals and method for using same CELL THERAPEUTICS, INC. (US) 2005-04-12 — — US disclosed
Send feedback